Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Morphologic analysis of pulmonary neuroendocrine tumors.

Lee SS, Kang M, Ha SY, An J, Roh MS, Ha CW, Han J.

Korean J Pathol. 2013 Feb;47(1):16-20. doi: 10.4132/KoreanJPathol.2013.47.1.16. Epub 2013 Feb 25.

2.

[Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].

Langfort R, Rudziński P, Burakowska B.

Pneumonol Alergol Pol. 2010;78(1):33-46. Review. Polish.

3.

Using electron microscopy and multivariate cluster analysis to determine diagnosis and prognosis in cases of neuroendocrine lung carcinoma.

Farhat CA, Parra ER, Rogers AV, Elian SN, Sheppard MN, Capelozzi VL.

J Bras Pneumol. 2008 Oct;34(10):804-11. English, Portuguese.

4.

[Trends in prognostic factors for neuroendocrine lung tumors].

García-Yuste M, Molins L, Matilla JM, González-Aragoneses F, López-Pujol J, Ramos G, de la Torre M; Estudio Multicéntrico Español de los Tumores Neuroendocrinos del Pulmón de la Sociedad Española de Neumología y Cirurgía Torácica (EMETNE-SEPAR).

Arch Bronconeumol. 2007 Oct;43(10):549-56. Spanish.

5.

Promyelocytic leukemia zinc finger and histone H1.5 differentially stain low- and high-grade pulmonary neuroendocrine tumors: a pilot immunohistochemical study.

Hechtman JF, Beasley MB, Kinoshita Y, Ko HM, Hao K, Burstein DE.

Hum Pathol. 2013 Jul;44(7):1400-5. doi: 10.1016/j.humpath.2012.11.014. Epub 2013 Feb 14.

PMID:
23416030
6.

Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors.

Sica G, Wagner PL, Altorki N, Port J, Lee PC, Vazquez MF, Saqi A.

Arch Pathol Lab Med. 2008 Dec;132(12):1889-95. doi: 10.1043/1543-2165-132.12.1889.

PMID:
19061285
7.

Divergent cyclin B1 expression and Rb/p16/cyclin D1 pathway aberrations among pulmonary neuroendocrine tumors.

Igarashi T, Jiang SX, Kameya T, Asamura H, Sato Y, Nagai K, Okayasu I.

Mod Pathol. 2004 Oct;17(10):1259-67.

8.

Head and neck large cell neuroendocrine carcinoma should be separated from atypical carcinoid on the basis of different clinical features, overall survival, and pathogenesis.

Kao HL, Chang WC, Li WY, Chia-Heng Li A, Fen-Yau Li A.

Am J Surg Pathol. 2012 Feb;36(2):185-92. doi: 10.1097/PAS.0b013e318236d822.

PMID:
22082601
9.

Clinical recommendations on the treatment of neuroendocrine carcinoma of the larynx: A meta-analysis of 436 reported cases.

van der Laan TP, Plaat BE, van der Laan BF, Halmos GB.

Head Neck. 2015 May;37(5):707-15. doi: 10.1002/hed.23666. Epub 2014 Jun 18. Review.

PMID:
24596175
10.

Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma.

Liu Y, Sturgis CD, Grzybicki DM, Jasnosz KM, Olson PR, Tong M, Dabbs DD, Raab SS, Silverman JF.

Mod Pathol. 2001 Sep;14(9):880-5.

11.

Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.

Caplin ME, Baudin E, Ferolla P, Filosso P, Garcia-Yuste M, Lim E, Oberg K, Pelosi G, Perren A, Rossi RE, Travis WD; ENETS consensus conference participants.

Ann Oncol. 2015 Aug;26(8):1604-20. doi: 10.1093/annonc/mdv041. Epub 2015 Feb 2. Review.

12.

Malignancy-associated X chromosome allelic losses in foregut endocrine neoplasms: further evidence from lung tumors.

D'Adda T, Bottarelli L, Azzoni C, Pizzi S, Bongiovanni M, Papotti M, Pelosi G, Maisonneuve P, Antonetti T, Rindi G, Bordi C.

Mod Pathol. 2005 Jun;18(6):795-805.

13.

Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.

Swarts DR, Ramaekers FC, Speel EJ.

Biochim Biophys Acta. 2012 Dec;1826(2):255-71. doi: 10.1016/j.bbcan.2012.05.001. Epub 2012 May 10. Review.

PMID:
22579738
14.
15.

High-grade neuroendocrine carcinomas of the lung highly express enhancer of zeste homolog 2, but carcinoids do not.

Findeis-Hosey JJ, Huang J, Li F, Yang Q, McMahon LA, Xu H.

Hum Pathol. 2011 Jun;42(6):867-72. doi: 10.1016/j.humpath.2010.09.019. Epub 2011 Feb 2.

PMID:
21292308
16.

[Four cases of primary neuroendocrine carcinoma in ear, nose, pharynx and larynx].

Feng Y, Xu G, Liu B, Wang H, Su X.

Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2003 Sep;17(9):549-50. Chinese.

PMID:
14658193
17.

Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid.

Travis WD, Rush W, Flieder DB, Falk R, Fleming MV, Gal AA, Koss MN.

Am J Surg Pathol. 1998 Aug;22(8):934-44.

PMID:
9706973
18.

Pulmonary large cell carcinomas with neuroendocrine features are high-grade neuroendocrine tumors.

Iyoda A, Hiroshima K, Baba M, Saitoh Y, Ohwada H, Fujisawa T.

Ann Thorac Surg. 2002 Apr;73(4):1049-54.

PMID:
11996239
19.

Pulmonary neuroendocrine tumors: incidence and prognosis of histological subtypes. A population-based study in Denmark.

Skuladottir H, Hirsch FR, Hansen HH, Olsen JH.

Lung Cancer. 2002 Aug;37(2):127-35.

PMID:
12140134
20.

The molecular pathogenesis and management of bronchial carcinoids.

Cakir M, Grossman A.

Expert Opin Ther Targets. 2011 Apr;15(4):457-91. doi: 10.1517/14728222.2011.555403. Epub 2011 Jan 29. Review.

PMID:
21275849

Supplemental Content

Support Center